Vimarsana
Biggest News Aggregation in the World

Page 27 - Trials Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trials Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trials Network Today - Breaking & Trending Today

The race is on - Vimarsana News

The race is on

The race is on - IAVI Report – Vol. 24, No. 1, 2020 - IAVI. Scientists are applying decades of HIV research experience to the development of SARS-CoV-2 vaccines

Source: iavi.org
Chris Beyrer Named Director of Duke Global Health Institute - Vimarsana News

Chris Beyrer Named Director of Duke Global Health Institute

Christopher C. Beyrer, MD, MPH, an internationally recognized epidemiologist who has worked on the front lines of HIV/AIDS and COVID-19 treatment and research, will be the next director of the Duke

Source: duke.edu
Science Says: Comedian, researchers tackle tough topics - Vimarsana News

Science Says: Comedian, researchers tackle tough topics

"Daily Show" host Trevor Noah joined Fred Hutch's Drs. Rachel Issaka and Michele Andrasik for a conversation about colorectal cancer screening and improving equity in health care and research.

Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, - Vimarsana News

Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance,

Fred Hutchinson Cancer Center is a unified adult cancer research and care center that is a clinically integrated part of UW Medicine

U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen - Vimarsana News

U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA...